Tag: pharmaceuticals

The Tarrytown company teamed with Sonoma Biotherapeutics Inc. of South San Francisco, California.

Japan has the world's third largest economy, behind the U.S. and China.

Utilizing an executive order to launch a National Biotechnology and Biomanufacturing Initiative, the Biden Administration aims to “drive biomedical innovation that supports the health...

“The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” Boers marvels. “It shows how important it is to invest in health care in the U.S.”

The drugmaker is looking to hire over 100 people in anticipation of FDA approval of Tyvaso DPI, used to treat pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

A computer security study by IBM finds companies and organizations involved in responding to the Covid-19 pandemic were attacked by cybercriminals twice as often...

Boers joined Boehringer Ingelheim in 1998 in Belgium, and came to the U.S. in 2016 as senior vice president of the Specialty Care Franchise; he has led the U.S. Human Pharma business since January 2017.

The report found that on average it took a company 279 days to realize that its data had been hacked or otherwise compromised and take action dealing with the breach.

The lawsuit, which New York State is also part of, charges price-fixing and market-rigging for the sale of more than 100 generic drugs.

The deal involves an initial cash consideration of $150 million on a cash-free and debt-free basis, plus an additional $90 million based on revenue goals.

This is the third collaboration between Ridgefield-based Boehringer Ingelheim and Vanderbilt to develop novel anticancer compounds.

Bigal comes to Purdue from Teva Pharmaceuticals, where he most recently served as chief scientific officer for its specialty organization.

The new initiative will present educational materials focusing on opioid abuse prevention, treatment, and recovery strategies.

Referring to the initial lawsuit as "the tip of the iceberg," Jepsen stated that "the prices of many generic drugs have skyrocketed.”

The lawsuit claims Purdue Pharma exaggerated the benefits of its opioids in comparison to other pain management solutions.